Healthcare -
Biotechnology - NASDAQ - US
$ 54.8
-1.03 %
$ 6.97 B
Market Cap
18.15
P/E
HALO - OTHER CURRENT ASSETS
Other Current Assets HALO - Halozyme Therapeutics, Inc.
48.6 M
LAST VALUE
-22.51%
2 YEAR CAGR
3.27%
5 YEAR CAGR
19.16%
10 YEAR CAGR